CA2850440C - Process for the preparation of isoxazolyl-methoxy-nicotinic acids - Google Patents

Process for the preparation of isoxazolyl-methoxy-nicotinic acids Download PDF

Info

Publication number
CA2850440C
CA2850440C CA2850440A CA2850440A CA2850440C CA 2850440 C CA2850440 C CA 2850440C CA 2850440 A CA2850440 A CA 2850440A CA 2850440 A CA2850440 A CA 2850440A CA 2850440 C CA2850440 C CA 2850440C
Authority
CA
Canada
Prior art keywords
compound
formula
isoxazol
methyl
ylmethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2850440A
Other languages
English (en)
French (fr)
Other versions
CA2850440A1 (en
Inventor
Pascal Dott
Steven Paul Hanlon
Stefan Hildbrand
Hans Iding
Andrew Thomas
Pius Waldmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to CA3112072A priority Critical patent/CA3112072C/en
Publication of CA2850440A1 publication Critical patent/CA2850440A1/en
Application granted granted Critical
Publication of CA2850440C publication Critical patent/CA2850440C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/05—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
    • C12Y305/05001—Nitrilase (3.5.5.1)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA2850440A 2011-10-20 2012-10-17 Process for the preparation of isoxazolyl-methoxy-nicotinic acids Active CA2850440C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3112072A CA3112072C (en) 2011-10-20 2012-10-17 Biocatalytical process for the preparation of isoxazolyl-methoxy-nicotinic acids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11185992.2 2011-10-20
EP11185992 2011-10-20
PCT/EP2012/070521 WO2013057123A1 (en) 2011-10-20 2012-10-17 Process for the preparation of isoxazolyl-methoxy-nicotinic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3112072A Division CA3112072C (en) 2011-10-20 2012-10-17 Biocatalytical process for the preparation of isoxazolyl-methoxy-nicotinic acids

Publications (2)

Publication Number Publication Date
CA2850440A1 CA2850440A1 (en) 2013-04-25
CA2850440C true CA2850440C (en) 2021-05-04

Family

ID=47019026

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2850440A Active CA2850440C (en) 2011-10-20 2012-10-17 Process for the preparation of isoxazolyl-methoxy-nicotinic acids
CA3112072A Active CA3112072C (en) 2011-10-20 2012-10-17 Biocatalytical process for the preparation of isoxazolyl-methoxy-nicotinic acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3112072A Active CA3112072C (en) 2011-10-20 2012-10-17 Biocatalytical process for the preparation of isoxazolyl-methoxy-nicotinic acids

Country Status (20)

Country Link
US (1) US8604062B2 (cg-RX-API-DMAC7.html)
EP (1) EP2768827B1 (cg-RX-API-DMAC7.html)
JP (1) JP5923174B2 (cg-RX-API-DMAC7.html)
KR (2) KR102262697B1 (cg-RX-API-DMAC7.html)
CN (1) CN103889978B (cg-RX-API-DMAC7.html)
AR (1) AR088358A1 (cg-RX-API-DMAC7.html)
AU (1) AU2012321095B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014009266B1 (cg-RX-API-DMAC7.html)
CA (2) CA2850440C (cg-RX-API-DMAC7.html)
DK (1) DK2768827T3 (cg-RX-API-DMAC7.html)
ES (1) ES2613802T3 (cg-RX-API-DMAC7.html)
HU (1) HUE031276T2 (cg-RX-API-DMAC7.html)
IL (1) IL231645A (cg-RX-API-DMAC7.html)
MX (1) MX2014004688A (cg-RX-API-DMAC7.html)
MY (1) MY164880A (cg-RX-API-DMAC7.html)
PL (1) PL2768827T3 (cg-RX-API-DMAC7.html)
RU (1) RU2014118966A (cg-RX-API-DMAC7.html)
SG (1) SG11201401626UA (cg-RX-API-DMAC7.html)
SI (1) SI2768827T1 (cg-RX-API-DMAC7.html)
WO (1) WO2013057123A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7403050B2 (ja) * 2017-08-28 2023-12-22 ユニバーシティ オブ メリーランド ボルチモア 気分障害のための新規ガンマアミノ酪酸型受容体モジュレーター
AU2019286312B2 (en) 2018-06-13 2023-08-17 F. Hoffmann-La Roche Ag New isoxazolyl ether derivatives as GABA A alpha5 PAM
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
US12649738B2 (en) 2020-03-26 2026-06-09 Richter Gedeon Nyrt. 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine derivatives as GABAA α5 receptor modulators
TWI901650B (zh) 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔3,4-c〕嗒衍生物
GB202013765D0 (en) * 2020-09-02 2020-10-14 Gw Res Ltd Method of preparing cannabinoids
CN116854680A (zh) * 2022-03-28 2023-10-10 上海赛默罗生物科技有限公司 异噁唑-杂环类衍生物、药物组合物和用途
CN119265168B (zh) * 2024-11-05 2025-06-20 江南大学 一种新型腈水解酶及其在烟酸生物合成中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE315033T1 (de) 1998-08-07 2006-02-15 Chiron Corp Subtituierte isoxazole derivate als estrogen rezeptor modulatore
US6551804B2 (en) * 1999-07-12 2003-04-22 E. I. Du Pont De Nemours And Company Process for preparing 4-cyanopentanoic acid
WO2003099793A1 (en) 2002-05-24 2003-12-04 Takeda Pharmaceutical Company Limited 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
CA2564429A1 (en) 2004-05-14 2005-12-01 Irm Llc Compounds and compositions as ppar modulators
PL1802566T3 (pl) 2004-10-01 2009-05-29 Hoffmann La Roche Podstawione heksafluoroizopropanolem pochodne eteru
ATE485269T1 (de) 2005-06-27 2010-11-15 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden
JP2009508905A (ja) 2005-09-19 2009-03-05 エフ.ホフマン−ラ ロシュ アーゲー GABAAα5逆アゴニストとしてのイソオキサゾロ誘導体
CN101277952B (zh) 2005-10-11 2011-09-28 弗·哈夫曼-拉罗切有限公司 异*唑衍生物
RU2426731C2 (ru) 2005-12-23 2011-08-20 Ф. Хоффманн-Ля Рош Аг Производные арил-изоксазоло-4-ил-оксадиазола
US7618973B2 (en) 2007-12-04 2009-11-17 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
JP5301557B2 (ja) * 2007-12-04 2013-09-25 エフ.ホフマン−ラ ロシュ アーゲー イソオキサゾロ−ピリジン誘導体
JP2012040448A (ja) * 2008-11-14 2012-03-01 Yasutaka Sakamoto マイクロバブル発生装置
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
KR101354416B1 (ko) 2009-05-07 2014-02-19 에프. 호프만-라 로슈 아게 감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체

Also Published As

Publication number Publication date
PL2768827T3 (pl) 2017-05-31
US20130102778A1 (en) 2013-04-25
KR20140084209A (ko) 2014-07-04
ES2613802T3 (es) 2017-05-26
MY164880A (en) 2018-01-30
CN103889978B (zh) 2017-02-15
BR112014009266A2 (pt) 2017-06-13
AR088358A1 (es) 2014-05-28
SG11201401626UA (en) 2014-05-29
MX2014004688A (es) 2014-05-28
KR102262697B1 (ko) 2021-06-11
EP2768827A1 (en) 2014-08-27
BR112014009266A8 (pt) 2020-04-22
US8604062B2 (en) 2013-12-10
IL231645A (en) 2016-09-29
AU2012321095A1 (en) 2013-05-09
CA2850440A1 (en) 2013-04-25
IL231645A0 (en) 2014-05-28
DK2768827T3 (en) 2017-02-13
JP2014530831A (ja) 2014-11-20
KR20200008671A (ko) 2020-01-28
WO2013057123A1 (en) 2013-04-25
NZ622214A (en) 2016-08-26
HUE031276T2 (hu) 2017-07-28
BR112014009266B1 (pt) 2021-05-04
SI2768827T1 (sl) 2017-04-26
AU2012321095B2 (en) 2015-08-20
CN103889978A (zh) 2014-06-25
EP2768827B1 (en) 2016-11-23
CA3112072A1 (en) 2013-04-25
JP5923174B2 (ja) 2016-05-24
CA3112072C (en) 2023-06-13
RU2014118966A (ru) 2015-11-27

Similar Documents

Publication Publication Date Title
CA3112072C (en) Biocatalytical process for the preparation of isoxazolyl-methoxy-nicotinic acids
US9650371B2 (en) Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
CN103797011B (zh) 作为c-Kit激酶抑制剂的化合物和组合物
ES2809535T3 (es) Derivados de imidazopiridina como moduladores de la actividad de TNF
US20120172355A1 (en) Aminodihydrothiazine derivatives substituted with a cyclic group
TWI797926B (zh) 經雜芳基取代之吡啶及使用方法
CN115209952B (zh) 经取代的吡唑并嘧啶及其用途
US20130210839A1 (en) Fused aminodihydropyrimidine derivative
EA026062B1 (ru) Производные пиразолкарбоксамида в качестве модуляторов рецепторов следовых аминов (taar) для применения при лечении различных расстройств, таких как депрессия, диабет и болезнь паркинсона
WO2019234115A1 (en) Alkoxy-substituted pyridinyl derivatives as lpa1 receptor antagonists and their use in the treatment of fibrosis
SG11202111162PA (en) Pyridin-3-yl derivatives
TWI475021B (zh) 新穎(雜環-四氫吡啶)(哌基)-1-烷酮及(雜環-二氫吡咯啶)(哌基)-1-烷酮衍生物及其作為p75抑制劑之用途
NZ622214B2 (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
US20160016947A1 (en) Substituted pyridizinone derivatives as pde10 inhibitors
HK1193610B (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
HK1193610A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
US7626029B2 (en) Method of selectively introducing amino substituent
WO2025162358A1 (en) Fto inhibitors of bicyclic structures

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20171016

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240923

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240923